IQVIA Holdings Inc. IQV

NYSE · Healthcare · Medical - Diagnostics & Research

$245.82

Close on Fri, 20 Nov 2026 · market value $40.5B

What the price is betting on

In line with its record

At $246, the price assumes revenue grows about 6.4% a year for five years, from $17.3B to about $22.5B by FY2030. That is about the same as what analysts expect for the next two years and about the same as the company's own last three years.

The price assumes6.4%
Analysts, next two years5.9%
Last 3 years5.4%

Revenue growth a year. The price figure comes from a reverse DCF at a 9.5% discount rate.

Track it and Parra checks each report against the path, and tells you when revenue falls behind it.

Own more than IQV? Check up to 5 of your stocks at once, free, no account.

0$10B$20B$30B$17.3B'22'23'24'25Sep '26'26'27'28'29'30What the price needsReportedAnalysts

Both sides

Three stories, three values

Bear

$214

Base

$243

Bull

$277

Today $246

  • Bear $214. Cash flow grows 4% a year for the next 5 years, slower than expected, then slows to long-run growth.
  • Base $243. Cash flow grows 6% a year for the next 5 years, as analysts expect, then slows to long-run growth.
  • Bull $277. Cash flow grows 9% a year for the next 5 years, faster than expected, then slows to long-run growth.

Stories set by rules from the company’s record.

Checkpoints

The revenue the price needs

  1. YearNeedsAnalysts expect
  2. FY2026$17.6B$17.5B, on the path
  3. FY2027$18.7B$18.5B, on the path
  4. FY2028$19.9B$19.7B, on the path
  5. FY2029$21.2B$21.1B, on the path
  6. FY2030$22.5B$22.7B, on the path

Each year's revenue at 6.4% growth from $17.3B in the 12 months to September 2026.

At a glance

Healthcare · Medical - Diagnostics & Research · listed on NYSE

Revenue, FY2025
$16.3B
Growth, 3 years a year
5.4%
Cash margin
13%
Net debt
$14B
Shares, 3-year change
−9%
Dividend yield
0%

What other healthcare prices are betting on

Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.